Floatz logo

Atropine

Cirrhosis and Chronic Liver Disease

Cairo UniversitySmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cirrhosis and Chronic Liver Disease cohort.

Asset / SponsorPhaseRating
.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO-
Cairo University
Phase 4BB
NEOSTIGMINE
Cairo University
Phase 4BB
Rocuronium
Cairo University
Phase 4BB

Same molecule, other indications

Atropine is also rated in:

Neuromuscular BlockadeDormant
BB
Indicative ·
70 / 100
View asset →
Obstructive Sleep ApneaDormant
BB
Indicative ·
68 / 100
View asset →
cardiac rhythm diseaseDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →